You have successfully logged out.

Hello !
Logout

EWMA 2025

Prontosan® 20 years in wound care

As part of our commitment to effective wound care, we are proudly celebrating 20 years of Prontosan®, the system that helps to cleanse, debride, and prevent infection in acute and chronic wounds.​

For two decades, Prontosan® has been your partner in improving the lives of patients around the world suffering from chronic wounds.

This milestone would not be possible without each of you, our customers, and the extraordinary contributions of every stakeholder.​

  • 0

    years of Prontosan® in the market

  • > 0

    Countries where Prontosan® is avaialble​

  • around

    0M

    Patients treated world wide​

Join us in our booth​

EWMA - GNEAUPP 2025 Conference

To celebrate this milestone together visit us at the EWMA 2025 Conference from March 26–28 in Barcelona and discover our pathway in wound care treatment. ​

You are part of this success!​

Find us on booth #65
 

#Prontosan20years​

Join our symposium

How to bring the therapeutic cleansing consensus to your real-world practice

There is more in this pathway of success

Discover our wound care portfolio and cutting-edge advancements in wound care therapy

Can’t make it to attend our symposium at EWMA congress? No problem!

Fill out the form below, and we'll ensure you get all the information you need. Let's stay connected!​

The responsible organization is B. Braun Avitum AG.

I can revoke my consent at any time by sending an e-mail to info@bbraun.com or by clicking on the unsubscribe link at the end of any marketing e-mail. 

For more information about the processing of your data and your data protection rights, please refer to our privacy notice.

Thank you for your inquiry.

check_circle

We will provide you with the symposium recording as soon as available after the EWMA Congress.

Your request could not be submitted. Please try again.

warning

References

  1. Malone M, Bjarnsholt T, McBain AJ, James GA, Stoodley P, Leaper D, Tachi M, Schultz G, Swanson T, Wolcott RD. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care. 2017 Jan 2;26(1):20-25. doi: 10.12968/ jowc.2017.26.1.20. PMID: 28103163.
  2. Bellingeri A, Falciani F, Traspedini P, Moscatelli A, Russo A, Tino G, Chiari P, Peghetti A. Effect of a wound cleansing solution on wound bed preparation and inflammation in chronic wounds: a single-blind RCT. J Wound Care. 2016;25(3):161-8.
  3. Rodríguez-Rodríguez N, Martínez-Jiménez I, García-Ojalvo A, Mendoza-Mari Y, Guillén-Nieto G, Armstrong DG, Berlanga-Acosta J. Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients. MEDICC Rev. 2021 Sep 17;24(1):44-58. doi: 10.37757/MR2021.V23.N3.8. PMID: 34653116.
  4. Vogt TN, Koller FJ, Santos PND, Lenhani BE, Guimarães PRB, Kalinke LP. Quality of life assessment in chronic wound patients using the Wound-QoL and FLQA-Wk instruments. Invest Educ Enferm. 2020 Oct;38(3):e11. doi: 10.17533/udea.iee.v38n3e11. PMID: 33306901; PMCID: PMC7885545.
  5. Banharak S, Panpanit L, Subindee S, Narongsanoi P, Sanun-Aur P, Kulwong W, Songtin P, Khemphimai W. Prevention and Care for Incontinence-Associated Dermatitis Among Older Adults: A Systematic Review. J Multidiscip Healthc. 2021 Oct 26;14:2983-3004. doi: 10.2147/JMDH. S329672. PMID: 34729012; PMCID: PMC8556723.